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Abstract
The extent to which the effect of risk factors on cognitive ageing is dependent on APOE ε4 remains unclear. The 
objective of this study is to examine whether APOE ε4 allele modifies the association between health behaviors and 
cognition in late midlife. Data are drawn from 5447 participants of the Whitehall II study, health behaviors were 
assessed in 1997-1999 (mean age = 55.6, Standard Deviation (SD) = 6.0) and APOE genotype and cognitive function in 
2002-2004 (mean age = 60.9, SD = 5.9). Among APOE ε4 non-carriers, current smokers had lower scores on memory 
(difference in T-score = -2.49, 95%CI: -3.37, -1.60), reasoning (-2.88, 95%CI: -3.74, -2.01), phonemic (-2.66, 95%CI: -3.56, -
1.76) and semantic (-2.38, 95%CI: -3.28, -1.47) fluency compared to never smokers. In APOE ε4 carriers, difference 
between current and never smokers was seen only for reasoning (-1.92, 95%CI: -3.31, -0.51). Interaction terms 
supported differential effects of smoking as a function of APOE ε4 status for memory (p = 0.01), and phonemic (p = 
0.008) and semantic fluency (p = 0.02). Cognitive scores were lower among non-drinkers compared to moderate 
drinkers, among the sedentary participants and those who ate fruits and vegetable less than 2 times per day 
irrespective of APOE ε4 status. This study suggests that the APOE ε4 allele modifies the association of smoking but not 
that of other health behaviors - alcohol consumption, physical activity, fruit and vegetable consumption - with 
cognitive function in late midlife.
Findings
Carriers of the apolipoprotein E (APOE) ε4 allele are at
increased risk of late onset Alzheimer's disease [1].
Among APOE ε4 carriers there is evidence of atypical
brain activity in young adulthood [2] and greater cogni-
tive decline in middle-age [3,4]. Recently, it has been sug-
gested that, in addition to these direct associations,
APOE ε4 might also influence cognition indirectly by
modifying the effect of non-genetic risk factors, such as
health behaviors, on cognitive ageing [5,6]. Indeed,
adverse health behaviors are risk factors for impaired
cognition and dementia [5,7]; however, a recent review
concluded that more research is needed to confirm or
refute the hypothesis of a differential effect of health
behaviors among APOE ε4 carriers [7]. Thus, the objec-
tive of the present study is to examine whether APOE ε4
allele modifies the association of smoking, alcohol con-
sumption, physical activity and dietary behavior with
cognitive function in late midlife.
Data are drawn from the Whitehall II study, established
in 1985 on 10 308 British civil servants (6895 men and
3413 women) [8]. The University College London ethics
committee approved the study and all participants gave
written consent to participate in the study. The study
population for the present analysis is composed of 5447
participants with complete data on health behaviors
assessed during 1997-1999 (wave 5 of the study, mean age
= 55.6, Standard Deviation (SD) = 6.0) and APOE geno-
type and cognitive function assessed during 2002-2004
(wave 7 of the study, mean age = 60.9 (SD = 5.9)).
APOE genotype Two TaqMan assays (Rs429358 and
Rs7412, Assay-On-Demand, Applied Biosystems) were
used and run on a 7900HT analyzer (Applied Biosys-
tems), and genotypes indicated by the Sequence Detec-
tion Software version 2.0 (Applied Biosystems). Each SNP
was found to be within Hardy Weinberg Equilibrium (χ2
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p > 0.4). Genotyping was repeated for 511 participants
and error rates were found to be < 0.15%. APOE ε2/ε3/ε4
haplotypes were created and participants were catego-
rized as APOE ε4 non-carriers and APOE ε4 carriers for
those with at least one ε4 allele.
Health behaviors were assessed via questionnaire
Smoking status was assessed using questions on current
and past smoking and categorized as never, past and cur-
rent smokers. Alcohol consumption was assessed via
questions on the number of alcoholic drinks ("measures"
of spirits, "glasses" of wine, and "pints" of beer) consumed
in the last seven days, converted to number of units of
alcohol with each unit corresponding to 8 grams of etha-
nol. Alcohol consumption was categorized as: abstinence
(none), moderate (1-14 units/week for women and 1-21
units/week for men), and high consumption (15 or more
units/week in women and 22 or more in men). Physical
activity  questionnaire included 20 items on frequency
and duration of participation in different physical activi-
ties (e.g. walking, sports, and gardening) that were used
to compute hours per week of moderate and vigorous
physical activity. This information was used to identify
those with sedentary habit, defined as less than one hour
per week of moderate physical activity and less than one
hour per week of vigorous physical activity. Dietary
behavior was assessed using a measure of frequency of
fruit and vegetable consumption with the question "How
often do you eat fresh fruit or vegetables?"; responses
were on an eight-point scale, ranging from 'seldom or
never' to 'two or more times a day'.
Cognitive function was measured with multiple tests
Short-term verbal memory was assessed with a 20-word
free recall test. Participants were presented a list of 20
one or two syllable words at two second intervals and
then had two minutes to recall in writing as many of the
words in any order. The AH4-I (Alice Heim 4-I) was used
to assess reasoning. This test is composed of a series of 65
verbal and mathematical reasoning items of increasing
difficulty [9]. It tests inductive reasoning, measuring the
ability to identify patterns and infer principles and rules.
Participants had 10 minutes to do this section. We used
two measures of verbal fluency: phonemic and semantic
[10]. Phonemic fluency was assessed via "S" words and
semantic fluency via "animal" words. Subjects were asked
to write as many words beginning with "S" and as many
animal names as they could. One minute was allowed for
each fluency test.
Covariates  in the analysis, assessed alongside the
health behaviors, were sex, age, socioeconomic position
indexed as 6-level British civil service employment grade
[8], and education (no or lower primary school, lower
secondary school, higher secondary school, university,
and higher university degree).
All cognitive scores were standardized to T-scores
which are similar to z-scores but have a mean of 50 and a
SD of 10 in order to allow comparison between tests. The
association between categories of health behaviors and
cognitive T-scores was examined using analysis of covari-
ance (ANCOVA). The difference in mean cognitive T-
score, as well as the 95% confidence intervals (CI),
adjusted for age and sex, was calculated across health
behavior categories separately for APOE ε4 non-carriers
and carriers. In order to examine whether the APOE ε4
allele modifies the association between health behaviors
and each cognitive measure, an interaction term between
A P O E  ε 4  s t a t u s  a n d  h e a l t h  b e h a v i o r  c a t e g o r i e s  w a s
included in the model containing the main effects, sepa-
rately for each health behavior. We also used multiple
analysis of covariance (MANCOVA) to assess the overall
interaction between each health behavior and APOE ε4
status for all cognitive measures considered together. The
use of MANCOVA serves two purposes; it takes the cor-
relation between the cognitive tests into account and pro-
vides a p value for the overall interaction term [11]. This
method reduces the likelihood of Type I error, common
when multiple outcomes are analysed separately. Finally,
in order to examine whether the results were robust to
the effects of socioeconomic position, all analyses were
repeated with additional adjustment for employment
grade and education.
Table 1 presents the characteristics of the participants
as a function of their APOE ε4 status. Among the 3929
non-carriers, 14.9% were smokers, 12.5% were alcohol
abstainers, 26.4% were sedentary, and 39.6% ate fruit and
vegetables less than 2 times per day. The corresponding
figures among the 1518 APOE ε4 carriers were no differ-
ent, 14.6%, 14.1%, 25.7%, and 41.5%, respectively.
The associations between health behaviors in 1997-
1999 and cognitive function in 2002-2004 as a function of
the APOE ε4 allele are presented in Table 2. Among the
APOE ε4 non-carriers, current smokers had lower scores
on memory (difference in T-score = -2.49, 95%CI: -3.37, -
1.60), reasoning (-2.88, 95%CI: -3.74, -2.01), phonemic (-
2.66, 95%CI: -3.56, -1.76) and semantic (-2.38, 95%CI: -
3.28, -1.47) fluency compared to never smokers. In the
APOE ε4 carriers, a corresponding difference between
current and never smokers was only seen for reasoning (-
1.92, 95%CI: -3.31, -0.51). Interaction terms for memory
(p = 0.01), phonemic (p = 0.008) and semantic fluency (p
= 0.02) supported differential effects of smoking as a
function of APOE ε4 status. Compared to never smokers,
ex-smokers had on average better scores in phonemic
(+1.35, 95%CI: 0.27, 2.42) and semantic (+1.27, 95%CI:
0.25, 2.30) fluency among the APOE ε4 carriers but not
among the non-carriers (p  for interaction = 0.04 and
0.006, respectively). MANCOVA also suggested an over-Sabia et al. Molecular Neurodegeneration 2010, 5:23
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all interaction between APOE ε4 status and both current
(p = 0.04) and past smoking (p = 0.02).
Cognitive scores were lower among non-drinkers com-
pared to moderate drinkers, among the sedentary partici-
pants and those who ate fruit and vegetables less than 2
times per day. These associations were present in both
APOE ε4 non-carriers and carriers with no evidence of
differential effects as a function of the APOE ε4 status (p
for interaction from MANCOVA was 0.37 for alcohol
abstinence, 0.31 for high alcohol consumption, 0.70 for
sedentary habit, and 0.69 for fruit and vegetable con-
sumption). In models further adjusted for employment
grade and education (Table 3), the effect sizes were some-
what attenuated in both APOE ε4 carriers and non-carri-
ers. However, the interaction terms remain unchanged
except that for past smoking.
These prospective data from over five thousand British
adults suggest that the APOE ε4 allele modifies the
impact of smoking but not that of other health behaviors
- alcohol consumption, physical activity, fruit and vegeta-
ble consumption - on cognitive function in late midlife.
Among the APOE ε4 non-carriers, current smokers had
lower scores on multiple cognitive tests, such as memory,
phonemic and semantic fluency, compared with never
smokers. A corresponding pattern was not observed
among the APOE ε4 carriers.
Our findings are in agreement with previous studies on
clinical outcomes which documented evidence of an
interaction between APOE ε4 and current smoking. In
those studies, a higher risk of dementia among smokers
was found, but only among APOE ε4 non-carriers [12-
16]. We also observed higher cognitive scores among ex-
Table 1: Characteristics of the study population.
APOE ε4 non-carriers APOE ε4 carriers
N3 9 2 9 1 5 1 8
Age (M, SD) 60.9 (5.9) 60.8 (5.9)
Women (N, %) 1071 (27.3) 384 (25.3)
Lower employment grade (N, %) 839 (21.4) 312 (20.6)
Less than secondary school (N, %) 1641 (41.8) 634 (41.8)
Smoking status (N, %)
Current 587 (14.9%) 221 (14.6%)
Past 1468 (37.4%) 560 (36.9%)
Never 1874 (47.7%) 737 (48.6%)
Alcohol consumption (N, %)
Abstinence 490 (12.5%) 214 (14.1%)
Moderate 2016 (51.3%) 749 (49.3%)
High 1423 (36.2%) 555 (36.6%)
Sedentary habit (N, %)
Yes 1039 (26.4%) 390 (25.7%)
No 2890 (73.6%) 1128 (74.3%)
Fruit & vegetable consumption less 
than 2 times/day (N, %)
Yes 1555 (39,6%) 630 (41,5%)
No 2374 (60,4%) 888 (58,5%)Sabia et al. Molecular Neurodegeneration 2010, 5:23
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Table 2: Association between health behaviors and cognitive function as a function of APOE ε4 status adjusted for 
socioeconomic variables.
Memory Reasoning Phonemic fluency Semantic fluency p for 
interaction‡
Health behaviors Difference† (95% CI) Difference† (95% CI) Difference† (95% CI) Difference† (95% CI)
Current smoking§
APOE ε4 non-carriers -2.49 (-3.37, -1.60)* -2.88 (-3.74, -2.01)* -2.66 (-3.56, -1.76)* -2.38 (-3.28, -1.47)*
APOE ε4 carriers -0.34 (-1.79, 1.11) -1.92 (-3.31, -0.51)* -0.35 (-1.82, 1.11) -0.34 (-1.74, 1.06)
p for interaction 0.01 0.24 0.008 0.02 0.04
Past smoking§
APOE ε4 non-carriers -0.21 (-0.89, 0.44) -0.44 (-1.08, 0.20) 0.05 (-0.62, 0.72) -0.39 (-1.06, 0.28)
APOE ε4 carriers 0.71 (-0.35, 1.78) 0.08 (-0.95, 1.11) 1.35 (0.27, 2.42)* 1.27 (0.25, 2.30)*
p for interaction 0.11 0.36 0.04 0.006 0.02
Alcohol abstinence#
APOE ε4 non-carriers -1.24 (-2.18, -0.30)* -3.80 (-4.71, -2.90)* -3.05 (-4.00, -2.10)* -2.57 (-3.52, -1.61)*
APOE ε4 carriers -2.16 (-3.62, -0.71)* -3.04 (-4.44, -1.63)* -2.88 (-4.34, -1.41)* -3.06 (-4.46, -1.66)*
p for interaction 0.22 0.43 0.88 0.48 0.37
High alcohol 
consumption#
APOE ε4 non-carriers 0.63 (-0.08, 1.34) 1.15 (0.47, 1.84)* 1.13 (0.41, 1.85)* 1.19 (0.47, 1.91)*
APOE ε4 carriers 1.19 (0.05, 2.32)* 0.90 (-0.19, 1.99) 1.96 (0.82, 3.10)* 0.77 (-0.33, 1.86)
p for interaction 0.39 0.73 0.23 0.55 0.31
Sedentary habit**
APOE ε4 non-carriers -0.90 (-1.55, -0.20)* -1.20 (-1.90, -0.50)* -1.50 (-2.23, -0.80)* -1.50 (-2.18, -0.80)*
APOE ε4 carriers -0.60 (-1.73, 0.53) -1.30 (-2.43, -0.30)* -1.30 (-2.46, -0.20)* -2.00 (-3.12, -1.00)*
p for interaction 0.92 0.72 0.90 0.25 0.70
Fruit & vegetable 
consumption less than 
2 times/day††
APOE ε4 non-carriers -1.50 (-2.15, -0.90)* -3.20 (-3.83, -2.60)* -2.10 (-2.75, -1.50)* -3.10 (-3.73, -2.50)*
APOE ε4 carriers -1.20 (-2.16, -0.20)* -3.00 (-3.92, -2.00)* -1.30 (-2.29, -0.30)* -2.70 (-3.67, -1.80)*
p for interaction 0.45 0.59 0.15 0.46 0.69
* p < 0.05.
† Mean difference in T-score of cognitive function in models adjusted for age and sex. ‡ p from MANCOVA.
§Difference with never smoking. # Difference with moderate alcohol consumption.
** Difference with non sedentary habit. †† Difference with the group eating fruit & vegetables 2 or more times a day.
smokers compared to never smokers among the APOE ε4
carriers. A previous study reported similar results for the
risk of Alzheimer's disease [12]. However, in our analysis
the effect of past smoking, compared with never smok-
ing, did not differ as a function of APOE ε4 status when
socio-economic position was taken into account. Thus,
the higher scores among the ex-smokers who were APOE
ε4 carriers compared to APOE ε4 non-carriers appeared
to be due to confounding by socioeconomic factors.
It is plausible that the effects of smoking in APOE ε4
carriers are attenuated as these individuals have been
shown to have fewer nicotinic receptor binding sites and
lower activity of choline acetyltransferase than non carri-
ers [17]. Smoking might counterbalance the deficit in nic-Sabia et al. Molecular Neurodegeneration 2010, 5:23
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Table 3: Association between health behaviors and cognitive function as a function of APOE ε4 status adjusted for 
socioeconomic variables.
Memory Reasoning Phonemic fluency Semantic fluency p for interaction‡
Health behaviors Difference† (95% CI) Difference† (95% CI) Difference† (95% CI) Difference† (95% CI)
Current smoking§
APOE ε4 non-carriers -1.65 (-2.53, -0.79)* -1.10 (-1.84, -0.36)* -1.46 (-2.32 -0.61)* -0.99 (-1.83, -0.14)*
APOE ε4 carriers 0.41 (-1.02, 1.84) -0.36 (-1.59, 0.86) 0.73 (-0.67, 2.12) 0.88 (-0.42, 2.17)
p for interaction 0.01 0.27 0.009 0.02 0.02
Past smoking§
APOE ε4 non-carriers 0.17 (-0.47, 0.82) 0.28 (-0.26, 0.83) 0.56 (-0.07, 1.19) 0.19 (-0.42, 0.82)
APOE ε4 carriers 0.76 (-0.28, 1.80) 0.15 (-0.75, 1.04) 1.40 (0.38, 2.42)* 1.30 (0.35, 2.25)*
p for interaction 0.30 0.68 0.22 0.06 0.17
Alcohol abstinence#
APOE ε4 non-carriers -0.12 (-1.06, 0.81) -1.07 (-1.86, -0.28)* -1.21 (-2.13, -0.30)* -0.51 (-1.40, 0.39)
APOE ε4 carriers -1.56 (-3.00, -0.12)* -1.65 (-2.88, -0.42)* -2.00 (-3.40, -0.59)* -1.97 (-3.28, -0.66)*
p for interaction 0.08 0.67 0.58 0.09 0.28
High alcohol 
consumption#
APOE ε4 non-carriers 0.25 (-0.45, 0.94) 0.33 (-0.26, 0.91) 0.55 (-0.13, 1.23) 0.53 (-0.14, 1.20)
APOE ε4 carriers 0.91 (-0.20, 2.03) 0.16 (-0.80, 1.11) 1.49 (0.40, 2.58)* 0.15 (-0.86, 1.17)
p for interaction 0.37 0.62 0.23 0.48 0.30
Sedentary habit**
APOE ε4 non-carriers -0.37 (-1.05, 0.32) 0.06 (-0.52, 0.64) -0.66 (-1.33, -0.00)* -0.52 (-1.18, 0.14)
APOE ε4 carriers -0.03 (-1.15, 1.09) -0.08 (-1.03, 0.88) -0.52 (-1.61, 0.57) -1.14 (-2.15, -0.12)*
p for interaction 0.81 0.88 0.64 0.35 0.71
Fruit & vegetable 
consumption less 
than 2 times/day††
APOE ε4 non-carriers -0.60 (-1.22, 0.01) -1.12 (-1.65, -0.60)* -0.65 (-1.26, -0.05)* -1.49 (-2.08, -0.90)*
APOE ε4 carriers -0.49 (-1.47, 0.50) -1.43 (-2.27, -0.59)* -0.19 (-1.16, 0.77) -1.53 (-2.43, -0.64)*
p for interaction 0.70 0.74 0.37 0.94 0.82
* p < 0.05.
† Mean difference in T-score of cognitive function in models adjusted for age, sex, employment grade, and education. ‡ p from MANCOVA.
§Difference with never smoking. # Difference with moderate alcohol consumption.
** Difference with non sedentary habit. †† Difference with the group eating fruit & vegetables 2 or more times a day.
otine receptors and the lack of acetylcholine found in
APOE ε4 carriers [14,18]. Another possible mechanism
behind the smaller impact of smoking in APOE ε4 carri-
ers relates to several processes associated with the APOE
ε4 allele that accelerate degenerative changes in arteries
and brain, such as a somewhat higher total blood choles-
terol, more oxidized blood lipids, and greater risk of coro-
nary heart disease [2,19,20]. Such genetic influences may
reduce the relative importance of other risk factors for
cognitive ageing, such as smoking. Given this, it is sur-
prising that there was no clear evidence of effect modifi-
c a t i o n  b y  A P O E  ε 4  o n  t h e  a s s o c i a t i o n  b e t w e e n  o t h e r
health behaviors and cognition. Our results confirm pre-
vious studies suggesting that the effect of health behav-
iors on cognition does not differ by APOE ε4 status for
alcohol [21-23], physical activity [21,24,25], or diet [26].
The strengths of this study include a detailed assess-
ment of health behaviors and a large battery of cognitiveSabia et al. Molecular Neurodegeneration 2010, 5:23
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tests covering multiple cognitive domains. However,
although our sample covered a wide socioeconomic
range, with annual full-time salaries ranging from £4,995
to £150,000, the data are exclusively from white-collar
civil servants and cannot therefore be assumed to be rep-
resentative of the general population. The use of multiple
testing increases the risk of Type 1 error and in order to
ensure the robustness of our findings we repeated the
analyses using MANCOVA to obtain an overall interac-
tion term. The conclusions were similar from both analy-
ses. In conclusion, this study suggests that smoking is
associated with lower cognitive function only among
APOE ε4 non-carriers. Presence of the APOE ε4 allele did
not modify the impact of other health behaviors on cog-
nition.
List of abbreviations
APOE: Apolipoprotein E; ANCOVA: analysis of covari-
ance; MANCOVA: multiple analysis of covariance; AH4-
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